Skip to content

Zinc and Selenium supplementation in patients with CKDu.

Effects of Selenium and Zinc supplementation in the progression of chronic kidney disease of uncertain etiology in Sri Lanka: Pilot single blinded randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2019/001
Enrollment
Unknown
Registered
2019-01-01
Start date
2019-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease of uncertain etiology in Sri Lanka.

Interventions

1. Study setting - Nephrology clinic, District General Hospital, Polonnaruwa 2. Randomization - Simple randomization without replacement. 3. There will be four arms of the study. Control group will

Sponsors

Department of Medicine, Faculty of Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Age 18-60 years • Able to provide informed consent and willing to complete the follow-up visit • Estimated glomerular filtration rate between 30 and 60 ml/min/1.73m2 • Suffering from CKDu (ie other identifiable causes of CKD excluded)

Exclusion criteria

Exclusion criteria: • History of allergy to Zinc or Selenium • Hemodialysis or peritoneal dialysis currently or within six months of recruitment • Renal transplant recipient • Pregnancy • Breast feeding

Design outcomes

Primary

MeasureTime frame
Rate of change in eGFR and change of urine albumin/ creatinine ratio between baseline and final follow-up. eGFR will be calculated from serum creatinine using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. [At the completion of three months.]

Secondary

MeasureTime frame
Changes in body mass index, blood pressure and hemoglobin. [At the completion of three months.]

Countries

Sri Lanka

Contacts

Public ContactDr. Prabath K Abeysundara

Senior Registrar in Internal Medicine

heshanprabathkularathne@yahoo.comTel: +94112953409

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026